Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02432001 · ClinicalTrials.gov registry record
Radiologically Guided Biopsies of mCRPC
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 256
- Enrollment target
NCT02432001 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 256 participants.
The verdict
NCT02432001 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 256 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand how cancer treatment may affect cancer cells. The research will involve genetic, molecular, cellular, and immunologic experiments using blood and tumor specimens. It is hoped that the information gained from these studies will lead to a greater understanding of castrate-resistant prostate cancer and potentially, improvements in cancer treatment. This is a tissue collection protocol requiring image-guided biopsies of metastatic, castration-resistant prostate cancer (mCRPC). The investigators will focus on enrolling patients with metastatic CRPC who have progressed while receiving novel AR-targeted therapeutics such as abiraterone and enzalutamide. This population of patients was selected because resistance develops relatively rapidly following potent inhibitors of AR activity and the mechanisms of resistance have to be better understood. Without comprehensive analysis of mCRPC tumor, the investigators will never gain a full understanding of the biology driving resistance in human disease and developing rational co-targeting approaches will not be possible.
Interventions
- PROCEDURE Image-Guided Biopsies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 256 participants |
| Start Date | 2013-02-22 |
| Est. Completion | 2020-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02432001
The ClinicalTrials.gov registry entry for NCT02432001 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 256 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Image-Guided Biopsies is the first listed.
NCT02432001 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02432001 about?
NCT02432001 is a clinical study titled "Radiologically Guided Biopsies of mCRPC". The purpose of this study is to better understand how cancer treatment may affect cancer cells. The research will involve genetic, molecular, cellular, and immunologic experiments using blood and tumor specimens. It is hoped that the information gained from these studies will lead to a greater under...
What is the current status of trial NCT02432001?
This trial is currently completed. The enrollment target is 256 participants. The study started on 2013-02-22. Estimated completion is 2020-01-01.
What interventions are being tested in trial NCT02432001?
The interventions under investigation include: Image-Guided Biopsies (PROCEDURE).
Who is sponsoring clinical trial NCT02432001?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.